Study of germ carriage that produces ESBL enzymes
Part of Infections clinical trials.
This study looks at whether certain bacteria that carry ESBL enzymes are spreading between people. To join, you would need lab-confirmed evidence that you carry these bacteria based on routine samples taken during usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 1 year
- Have lab-confirmed “ESBL-PE” bacteria in a specimen (like swab or stool)
- The sample must have been taken as part of routine clinical care
- The sample must be from a patient at University Hospital Basel
- The confirmed sample must have come from January 1, 2019 to December 31, 2019
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and studies lab-detected germs in hospital patients that produce special enzymes making some antibiotics less effective. It helps researchers understand how these resistant germs spread over time in Switzerland.
This trial looks at whether stopping extra “contact precautions” (special measures to prevent spread) is safe for older hospital patients who carry a certain type of hard-to-treat gut bacteria. It may reduce unnecessary isolation and improve comfort, while still aiming to prevent infections.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This study gathers information about blood infections to better understand them and improve care. It may help by providing detailed data on your specific infection.
This study builds a Swiss database using lab genetic testing (whole genome sequencing) plus basic patient information to track outbreaks of serious, drug-resistant, and sometimes high-infectious pathogens. Your data could help researchers understand how these germs spread and how to better prevent them.
This trial looks at how well certain penicillin-type antibiotics work for treating a bloodstream infection caused by a bacterium called Enterococcus faecalis. It may help doctors know which treatment is best for patients with this infection.
Hear when a new Hospital Acquired Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.